- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Keymed Biosciences Inc (2162)
Keymed Biosciences Inc stock price live, this page displays HK 2162 stock exchange data. View the 2162 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Keymed Biosciences Inc real time stock price chart below.
What Is the Keymed Biosciences Inc Stock Price Today?
The Keymed Biosciences Inc stock price today is 39.20.
What Is the Stock Symbol for Keymed Biosciences Inc?
The stock symbol for Keymed Biosciences Inc is "2162."
What Stock Exchange Does Keymed Biosciences Inc Trade On?
Keymed Biosciences Inc is listed and trades on the Hong Kong stock exchange.
Is Keymed Biosciences Inc a Good Stock to Buy?
Determining whether Keymed Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2162 quote. (ISIN: KYG5252B1023)
What Is the Keymed Biosciences Inc Stock Price Today?
The Keymed Biosciences Inc stock price today is 39.20.
What Is the Stock Symbol for Keymed Biosciences Inc?
The stock symbol for Keymed Biosciences Inc is "2162."
What Stock Exchange Does Keymed Biosciences Inc Trade On?
Keymed Biosciences Inc is listed and trades on the Hong Kong stock exchange.
Is Keymed Biosciences Inc a Good Stock to Buy?
Determining whether Keymed Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2162 quote. (ISIN: KYG5252B1023)
Hong Kong
Currency in HKD
39.20
-0.45(-1.13%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.90
40.60
52 wk Range
26.60
47.50
2162 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
38.9040.60
52 wk Range
26.6047.50
Keymed Biosciences Inc is currently considered to be trading at Fair valueExplore our list of undervalued stocks for hidden opportunities
Keymed Biosciences Inc is not on our AI-picked strategiesExplore current and previous stocks selected by AI
Try Warren AI research assistant for instant insights on Keymed Biosciences IncFrom metrics, to news, charts, and even a SWOT analysis - you can ask anything!
What you should know about Keymed Biosciences IncHolds more cash than debt on its balance sheetSignificant return over the last week
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2162 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
54.57
Upside
+39.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Keymed Biosciences Company Profile
Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary disease (COPD). The company is also developing CM326, a monoclonal antibody targeting thymic stromal lymphopoietin to treat moderate-to severe AD, CRSwNP, asthma, and COPD. In addition, it develops CMG901 for the treatment of solid tumors, and gastric and gastroesophageal cancers; and CM313, a humanized monoclonal antibody to treat relapsed or refractory multiple myeloma, lymphoma and other hematological malignancies, and systemic lupus erythematosus. Further, the company is developing CM338, an antagonist antibody against mannose-binding lectin associated serine protease-2. Additionally, it is developing CM355 for the treatment of relapsed or refractory non-Hodgkin’s lymphoma; CM336 to treat multiple myeloma; CM350 for the treatment of solid tumors; and CM369, an anti-CC chemokine receptor 8 monoclonal antibody. Keymed Biosciences Inc. was formerly known as 2Health Biosciences, Inc. The company was founded in 2016 and is headquartered in Chengdu, the People’s Republic of China.
Compare 2162 to Peers and Sector
Metrics to compare | 2162 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2162PeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.6x | −8.9x | −0.5x | |
PEG Ratio | 0.08 | 0.06 | 0.00 | |
Price/Book | 3.8x | 3.1x | 2.6x | |
Price / LTM Sales | 123.4x | 11.2x | 3.0x | |
Upside (Analyst Target) | 42.8% | 26.3% | 53.8% | |
Fair Value Upside | Unlock | 2.6% | 9.2% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 54.57
(+39.21% Upside)
FAQ
What Is the Keymed Biosciences (2162) Stock Price Today?
The Keymed Biosciences stock price today is 39.20.
What Stock Exchange Does Keymed Biosciences Trade On?
Keymed Biosciences is listed and trades on the Hong Kong stock exchange.
What Is the Stock Symbol for Keymed Biosciences?
The stock symbol for Keymed Biosciences is "2162."
What Is the Keymed Biosciences Market Cap?
As of today, Keymed Biosciences market cap is 10.80B.
What is Keymed Biosciences Earnings Per Share?
The Keymed Biosciences EPS is -2.84.
From a Technical Analysis Perspective, Is 2162 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.